STOCK TITAN

Citadel entities and Kenneth Griffin disclose 4.5% stake in HIVE (HIVE)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

HIVE Digital Technologies Ltd. Schedule 13G jointly filed by Citadel entities and Kenneth Griffin reporting shared beneficial ownership of HIVE common shares. The filing lists 11,511,599 shares (4.5%) held by Citadel Securities Group LP and Citadel Securities GP LLC, 8,758,788 shares (3.5%) held by Citadel Securities LLC, and 11,512,039 shares (4.5%) attributable to Kenneth Griffin. The percentages are calculated using 253,256,770 Shares outstanding as of February 16, 2026, per the filing note. The statement notes shared voting and dispositive powers and clarifies that ownership may include instruments exercisable or convertible into shares.

Positive

  • None.

Negative

  • None.

Insights

Large Citadel group holds single‑digit, disclosed stakes in HIVE.

These filings show passive shared beneficial ownership positions: Citadel Securities Group LP and related entities report around 11.5M shares (4.5%) and Citadel Securities LLC reports 8.76M shares (3.5%). Kenneth Griffin is reported with an attributable 11.512M shares (4.5%).

Percentages are anchored to February 16, 2026 outstanding shares. The filing describes shared voting/dispositive powers and possible inclusion of convertible/exercisable instruments; cash‑flow treatment and trading intent are not stated in the excerpt.

Shares outstanding (used for % calc) 253,256,770 shares as of February 16, 2026
Citadel Securities Group LP holdings 11,511,599 shares reported beneficial ownership, <b>4.5%</b> of class
Citadel Securities LLC holdings 8,758,788 shares reported beneficial ownership, <b>3.5%</b> of class
Kenneth Griffin attributable holdings 11,512,039 shares reported beneficial ownership, <b>4.5%</b> of class
Citadel Advisors / related entities 440 shares reported beneficial ownership, <b>0.0%</b> of class
Schedule 13G regulatory
"Jointly filed Schedule 13G reporting beneficial ownership positions"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
shared dispositive power regulatory
"Shared Dispositive Power 11,511,599.00 reported for certain entities"
beneficially own regulatory
"may be deemed to beneficially own 8,758,788 Shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
exercisable for or convertible into Shares financial
"Such owned Shares may include other instruments exercisable for or convertible into Shares"





433921103

(CUSIP Number)
04/17/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentages reported in this Schedule 13G are based upon 253,256,770 Shares outstanding as of February 16, 2026 (according to Exhibit 99.2 to the issuer's Form 6-K as filed with the Securities and Exchange Commission on February 17, 2026). Except as described in the preceding sentence, all Shares for the holdings of the reporting persons reported in this Schedule 13G are as of the opening of the market on April 24, 2026.


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Citadel Securities GP LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:04/24/2026
Citadel Securities LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:04/24/2026
Citadel Securities Group LP
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:04/24/2026
Citadel Advisors LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:04/24/2026
Citadel Advisors Holdings LP
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:04/24/2026
Citadel GP LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:04/24/2026
Kenneth Griffin
Signature:/s/ Seth Levy
Name/Title:Seth Levy, attorney-in-fact*
Date:04/24/2026

Comments accompanying signature: * Seth Levy is signing on behalf of Kenneth Griffin as attorney-in-fact pursuant to a power of attorney previously filed with the Securities and Exchange Commission, and hereby incorporated by reference herein. The power of attorney was filed as an attachment to a filing by Citadel Advisors LLC on Schedule 13G for Allakos Inc. on October 13, 2023.
Exhibit Information

Exhibit 99.1 - Joint Filing Agreement

FAQ

What stake does Citadel report in HIVE (HIVE)?

Citadel Securities Group LP and affiliates report 11,511,599 shares, representing 4.5% of outstanding shares. The filing lists shared voting and dispositive powers and ties percentages to 253,256,770 shares outstanding as of February 16, 2026.

How many HIVE shares does Kenneth Griffin have reported?

Kenneth Griffin is reported with an attributable 11,512,039 shares equal to 4.5% of the class. The filing states these holdings reflect shared voting and dispositive power and may include instruments exercisable or convertible into shares.

What is the basis for the percentage calculations in the Schedule 13G?

Percentages are calculated using 253,256,770 Shares outstanding as of February 16, 2026, cited in the filing. The Schedule 13G explicitly links the reported percentages to that outstanding share figure from an Exhibit referenced in the issuer's Form 6-K.

Does the filing state whether these holdings are sole or shared ownership?

The filing reports 0 sole voting power and nonzero shared voting and dispositive power for the listed Citadel entities and Mr. Griffin. It therefore describes these positions as shared beneficial ownership rather than sole control.